| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC3971 | P7 Peptide | Novel bFGF antagonist peptide, inhibiting breast cancer cell growth |
|
| DCC3972 | P7c3a20 | Neuroprotective agent, protecting ventral horn spinal cord motor neurons from cell death |
|
| DCC3973 | P97-in-17 | Novel potent inhibitor of the AAA+ ATPase p97 |
|
| DCC3974 | P97-in-23 | Novel potent inhibitor of the AAA+ ATPase p97 |
|
| DCC3975 | Pa Autoinducer | Pseudomonas aeruginosa autoinducer |
|
| DCC3976 | Pa-082 | Novel partial agonist of peroxisome proliferator-activated receptor-γ (PPARγ), recruiting PPARγ-coactivator-1α, preventing triglyceride accumulation, and potentiating insulin signaling in vitro |
|
| DCC3977 | Pa1 Dihydrochloride | Photoswitchable epithelial sodium channel (ENaC) blocker |
|
| DCC3978 | Paba/no | Novel glutathione-S-transferase-p-activated nitric oxide donor, inhibiting proliferation and inducing apoptosis by targeting PI3K/AKT/mTOR and MEK/ERK pathways in hepatocellular carcinoma cells |
|
| DCC3979 | Pad3-in-14b | Novel potent and selective inhibitor of protein arginine deiminase 3 (PAD3), having 15600 kinact/KI values and ≥10-fold selectivity for PAD3 over PADs 1, 2, and 4. |
|
| DCC3980 | pal-1045 | Partial DAT/5-HT transporter substrate |
|
| DCC3981 | pal-1046 | Full DAT/5-HT transporter substrate |
|
| DCC3982 | Pal-12 | Novel selective LYPLAL1 activator, increasing LYPLAL1’s catalytic activity likely by enhancing the efficiency of the catalytic triad charge-relay system, confering beneficial effects in a mouse model of diet-induced obesity |
|
| DCC3983 | pal-287 | Full DAT/5-HT transporter substrate; Non-neurotoxic releasing agent of serotonin, norepinephrine, and dopamine; Full agonist at 5-HT2B and partial agonist at 5-HT2C |
|
| DCC3984 | Pal-545 Hydrochloride | Potent dual dopamine-serotonin (DA/5-HT) releaser |
|
| DCC3985 | Palbociclib Dihydrochloride Featured | Selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6 |
|
| DCC3986 | Palmostatin M | Novel Ras-Signaling Modulator, targeting acyl protein thioesterase 1 (APT1) and 2 (APT2) in cells |
|
| DCC3987 | Palonosetron | Potent serotonin-3 (5-HT3) receptor antagonist |
|
| DCC3988 | Pam2cys | Novel TLR2 agonist as potential adjuvant for cancer vaccines |
|
| DCC3989 | Pancratistatin | Inhibitor of the Cell_cycle>cell cycle from G0/G1 to S phase with powerful antiparasite activity |
|
| DCC3990 | Panduratin A | Biological Active Reagents |
|
| DCC3991 | panomifene | Tamoxifen analogue; antiestrogenic |
|
| DCC3992 | Pan-raf/rtk Inhibitor I-16 | Novel potent pan-Raf and receptor tyrosine kinase inhibitor, potently inhibits all subtypes of Rafs with IC50 values of 3.49 (BRafV600E), 8.86 (ARaf), 5.78 (BRafWT), and 1.65 nM (CRaf), respectively |
|
| DCC3993 | Pao-pdt | Potent and highly selective small molecule inhibitor of thioredoxin reductase (TrxR) |
|
| DCC3994 | Pape-1 | Pathway Preferential Estrogen, activating the extranuclear signaling pathway without activity on the nuclear signaling pathway |
|
| DCC3996 | Para-aminoblebbistatin | Blebbistatin derivative, increasing water solubility, decreases the inherent fluorescence, stabilizing the molecule to circumvent its degradation by prolonged blue light exposure, and decreasing its phototoxicity while retaining the in vitro and in vivo a |
|
| DCC3997 | Para-cid-5951923 | Isomer of CID-5951923 |
|
| DCC3998 | Para-nitroblebbistatin | Selective cell-permeable inhibitor of non-muscle myosin II ATPases, being more stable and less phototoxic than Blebbistatin |
|
| DCC3999 | Paraoxon | Acetylcholinesterase inhibitor, the active metabolite of the insecticide parathion |
|
| DCC4000 | Paraquat Diiodide | Non-selective contact herbicide, killing green plant tissue on contact, being highly toxic and linked to Parkinson's disease, generating reactive oxygen species (ROS), which causes cell death and potentially leading to acute respiratory distress syndrome |
|
| DCC4001 | Parogrelil | Novel potent phosphodiesterase 3 inhibitor, suppressing the asthmatic response and showing both bronchodilating and anti-inflammatory effects |
|
